TY - JOUR AU - Fine, R. N. AU - Becker, Y. AU - De Geest, S. AU - Eisen, H. AU - Ettenger, R. AU - Evans, R. AU - Rudow, D. L. AU - McKay, D. AU - Neu, A. AU - Nevins, T. AU - Reyes, J. AU - Wray, J. AU - Dobbels, F. PY - 2009 DA - 2009// TI - Non-adherence consensus conference summary report JO - Am J Transplant VL - 9 UR - https://doi.org/10.1111/j.1600-6143.2008.02495.x DO - 10.1111/j.1600-6143.2008.02495.x ID - Fine2009 ER - TY - STD TI - World Health Organization. (2001). Innovative care for chronic conditions. Building blocks for actions. World Health Organization, www.who.int/chp/knowledge/publications/icccglobalreport.pdf?ua=1 (Assessed at July 2, 2014). UR - http://www.who.int/chp/knowledge/publications/icccglobalreport.pdf?ua=1 ID - ref2 ER - TY - JOUR AU - Wu, E. Q. AU - Guerin, A. AU - Yu, A. P. AU - Bollue, V. K. AU - Guo, A. AU - Griffin, J. D. PY - 2010 DA - 2010// TI - Retrospective real-world comparison of medical visits, costs and adherence between nilitinib and dasatinib in chronic myeloid leukaemia JO - Curr Med Res Opin VL - 26 UR - https://doi.org/10.1185/03007995.2010.533648 DO - 10.1185/03007995.2010.533648 ID - Wu2010 ER - TY - JOUR AU - Leendertse, A. J. AU - Egberts, A. C. G. AU - Stoker, L. J. AU - van den Bemt, P. M. L. A. PY - 2008 DA - 2008// TI - Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands JO - Arch Intern Med VL - 168 ID - Leendertse2008 ER - TY - STD TI - Sabaté, E. (2003). Adherence to long-term therapies, evidence for action. World Health Organization, apps.who.int/medicinedocs/pdf/s4883e/s4883e.pdf (Assessed at July 2, 2014). UR - http://apps.who.int ID - ref5 ER - TY - JOUR AU - Foulon, V. AU - Schoffski, P. AU - Wolter, P. PY - 2011 DA - 2011// TI - Patient adherence to oral anticancer drugs: an emerging issue in modern oncology JO - Acta Clin Belg VL - 66 ID - Foulon2011 ER - TY - JOUR AU - Hall, A. E. AU - Paul, C. AU - Bryant, J. AU - Lynagh, M. C. AU - Rowlings, P. AU - Enjeti, A. AU - Small, H. PY - 2016 DA - 2016// TI - To adhere or not to adhere: rates and reasons of medication adherence in hematological cancer patients JO - Crit Rev Oncol Hematol VL - 97 UR - https://doi.org/10.1016/j.critrevonc.2015.08.025 DO - 10.1016/j.critrevonc.2015.08.025 ID - Hall2016 ER - TY - JOUR AU - Verbrugge, M. AU - Verhaegue, S. AU - Lauwaert, K. AU - Beeckman, D. AU - Hecke van, A. PY - 2013 DA - 2013// TI - Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: systematic review JO - Cancer Treat Rev VL - 39 UR - https://doi.org/10.1016/j.ctrv.2012.12.014 DO - 10.1016/j.ctrv.2012.12.014 ID - Verbrugge2013 ER - TY - JOUR AU - Puts, M. T. AU - Tu, H. A. AU - Tourangeau, A. AU - Howell, D. AU - Fitch, M. AU - Springall, E. AU - Alibhai, S. M. PY - 2014 DA - 2014// TI - Factors influencing adherence to cancer treatment in older adults with cancer JO - A systematic review Annals of Oncology VL - 25 UR - https://doi.org/10.1093/annonc/mdt433 DO - 10.1093/annonc/mdt433 ID - Puts2014 ER - TY - JOUR PY - 2012 DA - 2012// TI - Investigating factors associated with adherence behaviour in patients with chronic myeloid leukemia: an observational patient-centered outcome study JO - Br J Cancer VL - 107 UR - https://doi.org/10.1038/bjc.2012.348 DO - 10.1038/bjc.2012.348 ID - ref10 ER - TY - STD TI - Sabaté, E. (2001). Adherence to long-term therapies: policy for action. World Health Organization, www.who.int/chp/knowledge/publications/adherencerep.pdf (Assessed at July 2, 2014). UR - http://www.who.int/chp/knowledge/publications/adherencerep.pdf ID - ref11 ER - TY - JOUR AU - Simpson, S. H. AU - Eurich, D. T. AU - Majumdar, S. R. AU - Padwal, R. S. AU - Tsuyuki, R. T. AU - Varney, J. AU - Johnson, J. A. PY - 2006 DA - 2006// TI - A meta-analysis of the association between adherence to drug therapy and mortality JO - Br Med J VL - 333 UR - https://doi.org/10.1136/bmj.38875.675486.55 DO - 10.1136/bmj.38875.675486.55 ID - Simpson2006 ER - TY - STD TI - Marin, D., Bazeos, A., Mahon, F.X., Eliasson, L., Milojkovic, D., Bua, M., Apperley, J.F., Szydlo, R., Desai, R., Kozlowski, K., Paliompeis, C., Latham, V., Foroni, L., Molimard, M., Reid, A., Rezvani, K., Lavallade de, H., Guallar, C., Goldman, J., Khorashad, J.S. (2010). Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib. J Clin Oncol, 28(14):2381–2388. ID - ref13 ER - TY - STD TI - Weingart, S.N., Brown, E., Bach, P.B., Eng, K., Johnson, S.A., Kuzel, T.M., Langbaum, T.S., Leedy, R.D., Muller, R.J., Newcomer, L.N., O'Brien, S., Reinke, D., Rubino, M., Saltz, L., Walters, R.S. (2008). NCCN task force report: oral chemotherapy. Journal of the National Comprehensive Cancer Network, 6 (sup. 3), s.1–14. ID - ref14 ER - TY - STD TI - Aisner, J. (2007). Overview of the changing paradigm in cancer treatment: oral chemotherapy. American Journal of Health-System Pharmacy, 64 (9) (sup 5) s. 4–7. ID - ref15 ER - TY - JOUR AU - Gater, A. AU - Heron, L. AU - Abetz-Webb, L. AU - Coombs, J. AU - Simmons, J. AU - Guilhot, F. AU - Rea, D. PY - 2012 DA - 2012// TI - Adherence to oral tyrosine kinase inhibitor therapies in chronic myeloid leukemia JO - Leuk Res VL - 36 UR - https://doi.org/10.1016/j.leukres.2012.01.021 DO - 10.1016/j.leukres.2012.01.021 ID - Gater2012 ER - TY - JOUR AU - Noens, L. AU - van Lierde, M. AU - De Bock, R. AU - Verhoef, G. AU - Zachée, P. AU - Berneman, Z. AU - Martiat, P. AU - Mineur, P. AU - van Eygen, K. AU - MacDonald, K. AU - de Geest, S. AU - Albrecht, T. AU - Abraham, I. PY - 2009 DA - 2009// TI - Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study JO - Blood VL - 113 UR - https://doi.org/10.1182/blood-2008-12-196543 DO - 10.1182/blood-2008-12-196543 ID - Noens2009 ER - TY - JOUR AU - Fialko, L. AU - Garety, P. A. AU - Kuipers, E. AU - Dunn, G. AU - Bebbington, P. E. AU - Fowler, D. AU - Freeman, D. PY - 2008 DA - 2008// TI - A large-scale validation study of the medication adherence rating scale (MARS) JO - Schizophr Res VL - 100 UR - https://doi.org/10.1016/j.schres.2007.10.029 DO - 10.1016/j.schres.2007.10.029 ID - Fialko2008 ER - TY - STD TI - Thompson, K., Kulkarni, J., Sergejew, A.A. (2000) Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophrenia Research. 5; 42(3):241–247. ID - ref19 ER - TY - JOUR AU - Horne, R. AU - Weinman, J. AU - Hankins, M. PY - 1999 DA - 1999// TI - The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication JO - Psychol Health VL - 14 UR - https://doi.org/10.1080/08870449908407311 DO - 10.1080/08870449908407311 ID - Horne1999 ER - TY - JOUR AU - Horne, R. AU - Weinman, J. PY - 1999 DA - 1999// TI - Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness JO - J Psychosom Res VL - 46 UR - https://doi.org/10.1016/S0022-3999(99)00057-4 DO - 10.1016/S0022-3999(99)00057-4 ID - Horne1999 ER - TY - JOUR AU - Zigmond, A. S. AU - Snaith, R. P. PY - 1983 DA - 1983// TI - The hospital anxiety and depression scale JO - Acta Psychiatr Scand VL - 67 UR - https://doi.org/10.1111/j.1600-0447.1983.tb09716.x DO - 10.1111/j.1600-0447.1983.tb09716.x ID - Zigmond1983 ER - TY - JOUR AU - Bjellan, I. AU - Dahl, A. A. AU - Haug, T. PY - 2002 DA - 2002// TI - The validity of the hospital anxiety and depression scale: an updated literature review JO - J Psychosom Res VL - 52 UR - https://doi.org/10.1016/S0022-3999(01)00296-3 DO - 10.1016/S0022-3999(01)00296-3 ID - Bjellan2002 ER - TY - JOUR AU - Spinhoven, P. AU - Ormel, J. AU - Sloekers, P. P. A. AU - Kempen, G. J. M. AU - Speckens, A. E. M. AU - Van Hemert, A. M. PY - 1997 DA - 1997// TI - A validation study of the hospital anxiety and depression scale (HADS) in different groups of Dutch subjects JO - Psychol Med VL - 27 UR - https://doi.org/10.1017/S0033291796004382 DO - 10.1017/S0033291796004382 ID - Spinhoven1997 ER - TY - STD TI - Evers, A.W.M., Kraaimaat, F.W., van Lankveld, W., Bijlsma, J.W.J. (1998). De Ziekte Cognitie Lijst (ZCL) (The Illness Cognition Questionnaire: ICQ). Gedragstherapie, 31:205–220. ID - ref25 ER - TY - JOUR AU - Evers, A. W. M. AU - Kraaimaat, F. W. AU - van Lankveld, W. AU - Jongen, P. H. J. AU - Jacobs, W. W. G. AU - Bijlsma, J. W. J. PY - 2001 DA - 2001// TI - Beyond unfavorable thinking: illness cognition questionnaire for chronic diseases JO - J Consult Clin Psychol VL - 69 UR - https://doi.org/10.1037/0022-006X.69.6.1026 DO - 10.1037/0022-006X.69.6.1026 ID - Evers2001 ER - TY - JOUR AU - Lauwerier, E. AU - Crombez, G. AU - Van Damme, S. AU - Goubert, L. AU - Vogelaers, D. AU - Evers, A. W. M. PY - 2009 DA - 2009// TI - The construct validity of the illness cognition questionnaire: the robustness of the three-factor structure across patients with chronic pain and chronic fatigue JO - International Journal of Behavioral Medicine VL - 17 UR - https://doi.org/10.1007/s12529-009-9059-z DO - 10.1007/s12529-009-9059-z ID - Lauwerier2009 ER - TY - JOUR AU - Aaronson, N. K. AU - Ahmedzai, S. AU - Bergman, B. AU - Bullinger, M. AU - Cull, A. AU - Duez, N. J. AU - Filiberti, A. AU - Flechtner, H. AU - Fleishman, S. B. AU - de Haes, J. C. J. M. AU - Kaasa, S. AU - Klee, M. C. AU - Osoba, D. AU - Razavi, D. AU - Rofe, P. B. AU - Schraub, S. AU - Sneeuw, K. C. A. AU - Sullivan, M. AU - Takeda, F. PY - 1993 DA - 1993// TI - The European organisation for research andbTreatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology JO - J Natl Cancer Inst VL - 85 UR - https://doi.org/10.1093/jnci/85.5.365 DO - 10.1093/jnci/85.5.365 ID - Aaronson1993 ER - TY - STD TI - Fayers, P., Aaronson, N.K., Bjordal, K., Curran, D., Groenvold, M. (2001). The EORTC QLQ-C30 Scoring Manual (3rd edition). European Organisation for Research and Treatment of Cancer, www.eortc.be/qol/files/SCManualQLQ-C30.pdf (Assessed at July 2, 2014). UR - http://www.eortc.be/qol/files/SCManualQLQ-C30.pdf ID - ref29 ER - TY - STD TI - Bouwman L, Eeltink CM, Visser O, Maaskant JM. Medication non-adherence in hematological-oncological patients in their home situation, the nurses group poster session. EBMT. 2015;2015 https://www.nature.com/bmt/journal/v50/n1s/pdf/bmt201532a.pdf UR - https://www.nature.com/bmt/journal/v50/n1s/pdf/bmt201532a.pdf ID - ref30 ER - TY - JOUR AU - Greenstein, S. AU - Siegal, B. PY - 1998 DA - 1998// TI - Compliance and noncompliance in patients with a functioning renal transplant: a multicenter study JO - Transplantation VL - 66 UR - https://doi.org/10.1097/00007890-199812270-00026 DO - 10.1097/00007890-199812270-00026 ID - Greenstein1998 ER - TY - STD TI - De Vera, M.A., Marcotte, G., Rai, S., Galo, J.S., Bhole, V. (2014). Medication Adherence in Gout: A Systematic Review. Arthritis Care & Research, (Epub, ahead of print). ID - ref32 ER - TY - JOUR AU - StCharles, M. AU - Bollu, V. K. AU - Hornyak, E. AU - Coombs, J. AU - Blanchette, C. M. AU - DeAngelo, D. J. PY - 2009 DA - 2009// TI - Predictors of treatment non-adherence in patients treated with Imatinib Mesylate for chronic myeloid leukemia JO - Blood VL - 114 UR - https://doi.org/10.1182/blood-2009-07-229948 DO - 10.1182/blood-2009-07-229948 ID - StCharles2009 ER - TY - STD TI - Larizza MA, Dooley MJ, Kay SK, Kong DCM. Factors influencing adherence to molecular therapies in Haematology-oncology outpatients. Pharmacy practice and research. 2006;36(2) ID - ref34 ER - TY - JOUR AU - Geissler, J. AU - Sharf, G. AU - Bombaci, F. AU - Daban, M. AU - De Jong, J. AU - Gavin, T. AU - Pelouchova, J. AU - Dziwinski, E. AU - Hasford, J. AU - Hoffmann, V. S. PY - 2017 DA - 2017// TI - Factors influencing adherence in CML and ways to improvement: Results of a patient-driven survey of 2546 patients in 63 countries JO - Journal of Cancer Research and Clinical Oncology VL - 143 UR - https://doi.org/10.1007/s00432-017-2372-z DO - 10.1007/s00432-017-2372-z ID - Geissler2017 ER - TY - STD TI - Dobbels F, Vanhaecke J, Dupont L, Nevens F, Verleden G, Pirenne J, Geest de S. Pretansplant predictors of posttransplant adherence and clinical outcome: an evidence base for pretransplant psychosocial screening. Transplantation 27; 87(10). 2009:1497–504. ID - ref36 ER - TY - JOUR AU - De Marchi, F. AU - Medeot, M. AU - Fanin, R. AU - Tiribelli, M. PY - 2017 DA - 2017// TI - How could patient reported outcomes improve patient management in chronic myeloid leukemia? JO - Expert Rev Hematol VL - 10 UR - https://doi.org/10.1080/17474086.2017.1262758 DO - 10.1080/17474086.2017.1262758 ID - De Marchi2017 ER - TY - STD TI - Timmers, L., Boons, C.C.L.M., Mangnus, D., Van de Ven, P.M., Van den Berg, P.H., Beeker, A., Swart, E.L., Honeywell, R.J., Peters, G. J., Boven, E., Hugtenburg, J.G. (2016). Adherence and Patients' Experiences with the Use of Capecitabine in Daily Practice. Frontiers in Pharmacol., Sep 21;7:310. ID - ref38 ER - TY - JOUR AU - Timmers, L. AU - Boons, C. C. L. M. AU - Kropff, F. AU - van de Ven, P. M. AU - Swart, E. L. AU - Smit, E. F. AU - Zweegman, S. AU - Kroep, J. R. AU - Timmer-Bonte, J. N. H. AU - Boven, E. AU - Hugtenburg, J. G. PY - 2013 DA - 2013// TI - Adherence and patients’ experiences with the use of oral anticancer agents JO - Acta Oncology VL - 53 UR - https://doi.org/10.3109/0284186X.2013.844353 DO - 10.3109/0284186X.2013.844353 ID - Timmers2013 ER - TY - JOUR AU - Jönsson, S. AU - Olsson, B. AU - Söderberg, J. AU - Wadenvik, H. PY - 2012 DA - 2012// TI - Good adherence to imatinib therapy among patients with chronic myeloid leukemia—a single-center observational study JO - Ann Hematol VL - 91 UR - https://doi.org/10.1007/s00277-011-1359-0 DO - 10.1007/s00277-011-1359-0 ID - Jönsson2012 ER -